In contrast, the combination of digitoxin plus MEK inhibitor caused tumour regression to the point of undetectability and the tumours did not grow back within 132 days of stopping treatment (Supplementary Fig. 6a). The gene discussed is MAP2K7; the disease is neoplasm.